0001225208-24-005567.txt : 20240503 0001225208-24-005567.hdr.sgml : 20240503 20240503163119 ACCESSION NUMBER: 0001225208-24-005567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REED JOHN C CENTRAL INDEX KEY: 0001181561 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24913719 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA STREET 2: WHQ 2134 CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0508 4 2024-05-01 0000200406 JOHNSON & JOHNSON JNJ 0001181561 REED JOHN C ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Innovative Medicine, R&D 0 Common Stock 2024-05-01 4 M 0 22255.0000 0.0000 A 22561.0000 D Common Stock 2024-05-01 4 F 0 10984.0000 144.5900 D 11577.0000 D Restricted Share Units 2024-05-01 4 M 0 22255.0000 0.0000 D Common Stock 22255.0000 53510.0000 D The Restricted Share Units awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of Restricted Share Units. /s/ Raavi Deol, as attorney-in-fact for John C. Reed 2024-05-03